Table 2.

Summary HIP incidence statistics for baseline and scenarios simulated from 2018 to 2040

	2020			2030			2040
	%	95% CI (±)	% reduction from baseline	%	95% CI (±)	% reduction from baseline	%	95% CI (±)	% reduction from baseline
Baseline	15.9	0.4	–	16.1	0.3	–	17.3	0.4	–
1. Population intervention	15.5	0.4	−3.0	13.3*	0.3	−17.6	13.8*	0.3	−20.5
2. Targeted prepregnancy	15.5	0.3	−2.8	15.3*	0.3	−5.2	16.2*	0.4	−6.2
3. Targeted interpregnancy reduction	15.6	0.3	−2.1	15.5*	0.3	−4.2	16.7*	0.4	−3.8
4. Combined population and targeted prepregnancy and interpregnancy	13.6	0.4	−14.4	11.5*	0.3	−28.8	11.8*	0.3	−32.1

*Significantly different from baseline at p<0.05.

HIP, hyperglycemia in pregnancy.